Search

Your search keyword '"Della Mora L"' showing total 12 results
Start Over Author "Della Mora L" Publisher elsevier bv
12 results on '"Della Mora L"'

3. Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes

Author

Schiavina, R., primary, Borghesi, M., additional, Dababneh, H., additional, Pultrone, C.V., additional, Chessa, F., additional, Concetti, S., additional, Gentile, G., additional, Vagnoni, V., additional, Romagnoli, D., additional, Della Mora, L., additional, Rizzi, S., additional, Martorana, G., additional, and Brunocilla, E., additional

Published
2014
Full Text
View/download PDF

6. 727 18F-FACBC PET/CT in comparison to 11c-choline for the detection of prostate cancer relapse after radical prostatectomy: A perspective study in 50 patients

Author

Schiavina, R., primary, Brunocilla, E., additional, Nanni, C., additional, Borghesi, M., additional, Ceci, F., additional, Zanoni, L., additional, Vagnoni, V., additional, Della, Mora L., additional, Cevenini, M., additional, Del Prete, C., additional, Fanti, S., additional, and Martorana, G., additional

Published
2014
Full Text
View/download PDF

7. 268 Patients with lymph-node metastasis after radical prostatectomy and pelvic lymph-node dissection are not all subject to the same risk of cancer death: Identifying different risk-category according to the number of positive nodes and Gleason score

Author

Schiavina, R., primary, Borghesi, M., additional, Brunocilla, E., additional, Vagnoni, V., additional, Della, Mora L., additional, Pultrone, C., additional, Del Prete, C., additional, Cevenini, M., additional, Dababneh, H., additional, and Martorana, G., additional

Published
2014
Full Text
View/download PDF

9. 656 Role of nephrometric scores (P.A.D.U.A and R.E.N.A.L score) in the prediction of warm ischemia time and postoperative complications in patients who underwent elective open or minimally invasive nephron sparing surgery for renal cell carcinoma

Author

Borghesi, M., primary, Schiavina, R., additional, Brunocilla, E., additional, Manferrari, F., additional, Della Mora, L., additional, Cevenini, M., additional, Mahmoud, Ghanem S., additional, Del Prete, C., additional, Pultrone, C., additional, Chessa, F., additional, and Martorana, G., additional

Published
2014
Full Text
View/download PDF

12. Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes

Author

Valerio Vagnoni, Francesco Chessa, Riccardo Schiavina, Marco Borghesi, Daniele Romagnoli, Hussam Dababneh, Cristian Vincenzo Pultrone, Giuseppe Martorana, L. Della Mora, Eugenio Brunocilla, Sergio Concetti, Giorgio Gentile, Simona Rizzi, Schiavina R, Borghesi M, Dababneh H, Pultrone CV, Chessa F, Concetti S, Gentile G, Vagnoni V, Romagnoli D, Della Mora L, Rizzi S, Martorana G, and Brunocilla E.

Subjects
Male, Surgical results, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Urology, Kaplan-Meier Estimate, Prostate cancer, Erectile Dysfunction, Surveys and Questionnaires, Adjuvant therapy, medicine, Humans, Potency, In patient, Aged, Retrospective Studies, Aged, 80 and over, Prostatectomy, Urinary continence, business.industry, Prostatic Neoplasms, General Medicine, medicine.disease, Treatment Outcome, Urinary Incontinence, Erectile dysfunction, Italy, prostatectomia radicale, Oncology, Surgery, business, Radical retropubic prostatectomy
Abstract

Objective: To offer a comprehensive account of surgical outcomes on a defined series of patients treated with radical retropubic prostatectomy (RRP) for prostate cancer in a single European Center after 5-year minimum follow-up according to the Survival, Continence and Potency (SCP) system. Material and methods: We evaluated our Institutional database of patients who underwent RRP from November 1995 to September 2008. Oncological and functional outcomes were reported according to the recently proposed SCP system. Results: The 5- and 10-year biochemical recurrence-free survival rates were 80.1% and 55.8%, respectively. At the end of follow-up, 611 (78.5%) patients were fully continent (C0), 107 (13.8%) used 1 pad for security (C1) and 60 (7.7%) patients were incontinent (C2). Of the 112 patients who underwent nerve-sparing RRP, 22 (19.6%) were fully potent without aids (P0), 13 (11.6%) were potent with assumption of PDE-5 inhibitors (P1) and 77 (68.8%) experienced erectile dysfunction (P2). The combined SCP outcomes were reported together only in 95 (12.2%) evaluable patients. In patients preoperatively continent and potent, who received a nerve-sparing and did not require adjuvant therapy, oncological and functional success was attained by 29 (30.5%) patients. In the subgroup of 508 patients not evaluable for potency recovery, oncological and continence outcomes were obtained in 357 patients (70.3%). Conclusion: Survival, Continence and Potency (SCP) classification offer a comprehensive report of surgical results, even in those patients who do not represent the best category, thus allowing to provide a much more accurate evaluation of outcomes after RP. 2014 Elsevier Ltd. All rights reserved.

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results